Impact of the coronavirus disease 2019 pandemic on prescriptions for antiretroviral drugs for HIV treatment in the United States, 2019-2021.

ABSTRACT:

Objective

To assess disruption in healthcare services for HIV treatment by national emergency in response to the coronavirus disease 2019 (COVID-19) pandemic in the United States.

Design

Time-series analysis.

Methods

We analyzed the IQVIA Real World Data-Longitudinal Prescriptions Database and calculated time trends in the weekly number of persons with active antiretroviral prescriptions for HIV treatment, and of persons who obtained antiretroviral prescriptions during January 2017-March 2021. We used interrupted time-series models to estimate the impact of the COVID-19 pandemic on antiretroviral therapy (ART) use between March 2020 and March 2021.

Results

We found that the weekly number of persons with active antiretroviral prescriptions decreased by an averag

SUBMITTER: Zhu W 

PROVIDER: S-EPMC10773577 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature